Search

Author/Creator Sebolt-Leopold, Judith

1. THER-29. NOVEL DUAL EGFR/PI3-KINASE INHIBITORS SHOW ENHANCED POTENCY, STRONGER PATHWAY SUPPRESSION AND TARGETING OF METABOLIC PROPERTIES IN PEDIATRIC AND ADULT HIGH GRADE GLIOMA MODELS THAN SINGLE KINASE INHIBITORS. (23rd April 2019)

Authors:
Sun, Yusha; Bailey, Cavan; Whitehead, Christopher; Sebolt-Leopold, Judith; Chandra, Joya
Journal:
Neuro-oncology
Issue:
Volume 21(2019)Supplement 2
Page Start:
ii120
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. DDDR-25. CO-INHIBITION OF KINASE SIGNALING PATHWAYS AND EPIGENETIC REGULATORS OVERCOMES COMPENSATORY EFFECTS IN PEDIATRIC HIGH-GRADE GLIOMAS. (14th November 2022)

Authors:
Adams, Jack; Stitzlein, Lea; Singh, Melissa; Su, Xiaoping; Lu, Yue; Bailey, Cavan; Monje, Michelle; Whitehead, Christopher; Sebolt-Leopold, Judith; Chandra, Joya
Journal:
Neuro-oncology
Issue:
Volume 24(2022)Supplement 7
Page Start:
vii104
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Dual inhibition of allosteric mitogen-activated protein kinase (MEK) and phosphatidylinositol 3-kinase (PI3K) oncogenic targets with a bifunctional inhibitor. Issue 7 (1st April 2015)

Authors:
Van Dort, Marcian E.; Galbán, Stefanie; Wang, Hanxiao; Sebolt-Leopold, Judith; Whitehead, Christopher; Hong, Hao; Rehemtulla, Alnawaz; Ross, Brian D.
Journal:
Bioorganic & medicinal chemistry
Issue:
Volume 23:Issue 7(2015)
Page Start:
1386
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗